{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:33:19Z","timestamp":1782372799265,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04016-5","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:23:35Z","timestamp":1760012615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rectal metastasis as the initial presentation of primary lung adenocarcinoma with an EGFR L858R mutation: a case report"],"prefix":"10.1186","volume":"23","author":[{"given":"Rui","family":"Nian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shushen","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"1","key":"4016_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-73389-6","volume":"14","author":"T Xie","year":"2024","unstructured":"Xie T, et al. Distant metastasis patterns among lung cancer subtypes and impact of primary tumor resection on survival in metastatic lung cancer using SEER database. Sci Rep. 2024;14(1):22445.","journal-title":"Sci Rep"},{"issue":"11","key":"4016_CR2","doi-asserted-by":"publisher","first-page":"8794","DOI":"10.3390\/curroncol29110691","volume":"29","author":"HK Park","year":"2022","unstructured":"Park HK, et al. Patterns of extrathoracic metastasis in lung cancer patients. Curr Oncol. 2022;29(11):8794\u2013801.","journal-title":"Curr Oncol"},{"issue":"18","key":"4016_CR3","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1016\/j.ejca.2006.08.030","volume":"42","author":"A Yoshimoto","year":"2006","unstructured":"Yoshimoto A, Kasahara K, Kawashima A. Gastrointestinal metastases from primary lung cancer. Eur J Cancer. 2006;42(18):3157\u201360.","journal-title":"Eur J Cancer"},{"issue":"2","key":"4016_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00432-008-0424-0","volume":"135","author":"MS Kim","year":"2009","unstructured":"Kim MS, et al. Gastrointestinal metastasis of lung cancer with special emphasis on a long-term survivor after operation. J Cancer Res Clin Oncol. 2009;135(2):297\u2013301.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"4016_CR5","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.3892\/ol.2017.6382","volume":"14","author":"N Taira","year":"2017","unstructured":"Taira N, et al. Analysis of gastrointestinal metastasis of primary lung cancer: clinical characteristics and prognosis. Oncol Lett. 2017;14(2):2399\u2013404.","journal-title":"Oncol Lett"},{"issue":"4","key":"4016_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s13691-021-00502-1","volume":"10","author":"Y Kikuchi","year":"2021","unstructured":"Kikuchi Y, et al. Clinicopathological characteristics of colorectal metastases from lung cancer: systematic review of the case reports in the Japanese literature. Int Cancer Conf J. 2021;10(4):266\u201373.","journal-title":"Int Cancer Conf J"},{"issue":"21","key":"4016_CR7","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"350","author":"TJ Lynch","year":"2004","unstructured":"Lynch TJ, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004;350(21):2129\u201339.","journal-title":"N Engl J Med"},{"issue":"12","key":"4016_CR8","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.21037\/tcr-23-956","volume":"12","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Wang R, Xu L. Clinical advances in EGFR-TKI combination therapy for EGFR-mutated NSCLC: a narrative review. Transl Cancer Res. 2023;12(12):3764\u201378.","journal-title":"Transl Cancer Res"},{"key":"4016_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030629","author":"JA Marin-Acevedo","year":"2023","unstructured":"Marin-Acevedo JA, et al. Treatment strategies for non-small cell lung cancer with common EGFR mutations: a review of the history of EGFR TKIs approval and emerging data. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15030629.","journal-title":"Cancers (Basel)"},{"key":"4016_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102824","volume":"130","author":"C Corvaja","year":"2024","unstructured":"Corvaja C, et al. Advancements in fourth-generation EGFR TKIs in EGFR-mutant NSCLC: bridging biological insights and therapeutic development. Cancer Treat Rev. 2024;130:102824.","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"4016_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5858\/arpa.2016-0579-CP","volume":"142","author":"RP Graham","year":"2018","unstructured":"Graham RP, et al. Worldwide frequency of commonly detected EGFR mutations. Arch Pathol Lab Med. 2018;142(2):163\u20137.","journal-title":"Arch Pathol Lab Med"},{"issue":"27","key":"4016_CR12","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1200\/JCO.21.02641","volume":"40","author":"S Lu","year":"2022","unstructured":"Lu S, et al. AENEAS: a randomized phase III trial of aumolertinib versus gefitinib as first-line therapy for locally advanced or metastaticnon-small-cell lung cancer with EGFR exon 19 deletion or L858R mutations. J Clin Oncol. 2022;40(27):3162\u201371.","journal-title":"J Clin Oncol"},{"issue":"5","key":"4016_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s40265-022-01695-2","volume":"82","author":"M Shirley","year":"2022","unstructured":"Shirley M, Keam SJ. Aumolertinib: a review in non-small cell lung cancer. Drugs. 2022;82(5):577\u201384.","journal-title":"Drugs"},{"issue":"6","key":"4016_CR14","first-page":"9766","volume":"15","author":"Y Hu","year":"2018","unstructured":"Hu Y, et al. Gastrointestinal metastasis of primary lung cancer: an analysis of 366 cases. Oncol Lett. 2018;15(6):9766\u201376.","journal-title":"Oncol Lett"},{"issue":"3","key":"4016_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0954-6111(95)90252-X","volume":"89","author":"AO Johnson","year":"1995","unstructured":"Johnson AO, Allen MB. Rectal metastases from small cell lung cancer. Respir Med. 1995;89(3):223\u20135.","journal-title":"Respir Med"},{"issue":"1","key":"4016_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s40792-019-0722-6","volume":"5","author":"Y Suzuki","year":"2019","unstructured":"Suzuki Y, et al. Metachronous rectal metastasis from pulmonary adenocarcinoma after 11 years of chemo-, immuno-, and radiotherapy for recurrent lesions: a case report. Surg Case Rep. 2019;5(1):151.","journal-title":"Surg Case Rep"},{"issue":"5","key":"4016_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1046\/j.1365-2559.2002.01387.x","volume":"40","author":"PG Chu","year":"2002","unstructured":"Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40(5):403\u201339.","journal-title":"Histopathology"},{"key":"4016_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.humpath.2018.10.009","volume":"84","author":"H Vidarsdottir","year":"2019","unstructured":"Vidarsdottir H, et al. Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases. Hum Pathol. 2019;84:221\u201330.","journal-title":"Hum Pathol"},{"issue":"1","key":"4016_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1046\/j.1365-2559.2000.00801.x","volume":"36","author":"O Kaufmann","year":"2000","unstructured":"Kaufmann O. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology. 2000;36(1):8\u201316.","journal-title":"Histopathology"},{"issue":"2","key":"4016_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00129039-200206000-00001","volume":"10","author":"SK Lau","year":"2002","unstructured":"Lau SK, Luthringer DJ, Eisen RN. Thyroid transcription factor-1: a review. Appl Immunohistochem Mol Morphol. 2002;10(2):97\u2013102.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"4016_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/00000478-200303000-00004","volume":"27","author":"G Rossi","year":"2003","unstructured":"Rossi G, et al. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases. Am J Surg Pathol. 2003;27(3):311\u201324.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"4016_CR22","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1309\/9W8D3XCVLRA3858A","volume":"122","author":"G Rossi","year":"2004","unstructured":"Rossi G, et al. TTF-1, cytokeratin 7, 34betaE12, and CD56\/NCAM immunostaining in the subclassification of large cell carcinomas of the lung. Am J Clin Pathol. 2004;122(6):884\u201393.","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"4016_CR23","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00428-024-03926-1","volume":"485","author":"K Moller","year":"2024","unstructured":"Moller K, et al. TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entities. Virchows Arch. 2024;485(5):815\u201328.","journal-title":"Virchows Arch"},{"issue":"9","key":"4016_CR24","first-page":"2892","volume":"5","author":"A Midha","year":"2015","unstructured":"Midha A, Dearden S, McCormack R. EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII). Am J Cancer Res. 2015;5(9):2892\u2013911.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"4016_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1200\/JCO.2015.62.0096","volume":"34","author":"DS Tan","year":"2016","unstructured":"Tan DS, Mok TS, Rebbeck TR. Cancer genomics: diversity and disparity across ethnicity and geography. J Clin Oncol. 2016;34(1):91\u2013101.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4016_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40291-021-00563-1","volume":"26","author":"B Melosky","year":"2022","unstructured":"Melosky B, et al. Worldwide prevalence of epidermal growth factor receptor mutations in non-small cell lung cancer: a meta-analysis. Mol Diagn Ther. 2022;26(1):7\u201318.","journal-title":"Mol Diagn Ther"},{"issue":"8","key":"4016_CR27","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.prp.2016.06.005","volume":"212","author":"E Tsiambas","year":"2016","unstructured":"Tsiambas E, et al. EGFR gene deregulation mechanisms in lung adenocarcinoma: a molecular review. Pathol Res Pract. 2016;212(8):672\u20137.","journal-title":"Pathol Res Pract"},{"key":"4016_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2024.101064","volume":"49","author":"JQ Trinh","year":"2024","unstructured":"Trinh JQ, Abughanimeh O. Current management of uncommon EGFR mutations in non-small cell lung cancer. Curr Probl Cancer. 2024;49:101064.","journal-title":"Curr Probl Cancer"},{"issue":"1","key":"4016_CR29","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001008","volume":"2","author":"M Olivier","year":"2010","unstructured":"Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol. 2010;2(1):a001008.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"9","key":"4016_CR30","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/humu.23035","volume":"37","author":"L Bouaoun","year":"2016","unstructured":"Bouaoun L, et al. TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data. Hum Mutat. 2016;37(9):865\u201376.","journal-title":"Hum Mutat"},{"issue":"4","key":"4016_CR31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.21037\/atm-22-412","volume":"10","author":"Z Fan","year":"2022","unstructured":"Fan Z, et al. Genomic landscape and prognosis of patients with TP53-mutated non-small cell lung cancer. Ann Transl Med. 2022;10(4):188.","journal-title":"Ann Transl Med"},{"key":"4016_CR32","doi-asserted-by":"publisher","first-page":"108452","DOI":"10.1016\/j.lungcan.2025.108452","volume":"204","author":"J Feng","year":"2025","unstructured":"Feng J, et al. Prognostic and predictive effects of TP53 co-mutation in patients with non-small cell lung cancer with rare treatable driver mutations. Lung Cancer. 2025;204:108452.","journal-title":"Lung Cancer"},{"issue":"5","key":"4016_CR33","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2022.13504","volume":"24","author":"B Lan","year":"2022","unstructured":"Lan B, et al. Concurrent TP53 mutations predict a poor prognosis of EGFR-mutant NSCLCs treated with tkis: an updated systematic review and meta-analysis. Oncol Lett. 2022;24(5):384.","journal-title":"Oncol Lett"},{"issue":"1","key":"4016_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.21037\/tlcr-21-754","volume":"11","author":"J Roeper","year":"2022","unstructured":"Roeper J, et al. TP53 co-mutations as an independent prognostic factor in 2nd and further line therapy-EGFR mutated non-small cell lung cancer IV patients treated with osimertinib. Transl Lung Cancer Res. 2022;11(1):4\u201313.","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"4016_CR35","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12885-020-06805-5","volume":"20","author":"K Qin","year":"2020","unstructured":"Qin K, et al. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis. BMC Cancer. 2020;20(1):328.","journal-title":"BMC Cancer"},{"issue":"14","key":"4016_CR36","doi-asserted-by":"publisher","first-page":"14556","DOI":"10.18632\/aging.103502","volume":"12","author":"L Zhao","year":"2020","unstructured":"Zhao L, et al. TP53 somatic mutations are associated with poor survival in non-small cell lung cancer patients who undergo immunotherapy. Aging. 2020;12(14):14556\u201368.","journal-title":"Aging"},{"issue":"1","key":"4016_CR37","doi-asserted-by":"publisher","first-page":"202","DOI":"10.21037\/tlcr-20-674","volume":"10","author":"A Pavan","year":"2021","unstructured":"Pavan A, et al. Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome. Transl Lung Cancer Res. 2021;10(1):202\u201320.","journal-title":"Transl Lung Cancer Res"},{"key":"4016_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/947524","volume":"2012","author":"S Cedres","year":"2012","unstructured":"Cedres S, et al. Rectal metastases from squamous cell carcinoma: a case report and review of the literature. Case Rep Med. 2012;2012:2012:p947524.","journal-title":"Case Rep Med"},{"issue":"3","key":"4016_CR39","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1759-7714.2011.00091.x","volume":"3","author":"SH Han","year":"2012","unstructured":"Han SH, et al. Solitary rectal metastasis from primary small cell lung carcinoma. Thorac Cancer. 2012;3(3):284\u20136.","journal-title":"Thorac Cancer"},{"issue":"4","key":"4016_CR40","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3892\/ol.2015.2893","volume":"9","author":"S Lu","year":"2015","unstructured":"Lu S, et al. Multiple cutaneous and intestinal metastases in lung cancer: a case report. Oncol Lett. 2015;9(4):1541\u20134.","journal-title":"Oncol Lett"},{"issue":"3","key":"4016_CR41","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1308\/rcsann.2016.0088","volume":"98","author":"D Thurston","year":"2016","unstructured":"Thurston D, et al. Non-small cell lung cancer with distal cutaneous metastases in a patient with a previously treated colorectal carcinoma. Ann R Coll Surg Engl. 2016;98(3):e47\u20138.","journal-title":"Ann R Coll Surg Engl"},{"issue":"1","key":"4016_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/deo2.70127","volume":"6","author":"S Mukawa","year":"2026","unstructured":"Mukawa S, et al. Rectal metastasis from lung cancer diagnosed by endoscopic ultrasound-guided fine needle biopsy: a case report. DEN Open. 2026;6(1):e70127.","journal-title":"DEN Open"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04016-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04016-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04016-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:06:52Z","timestamp":1760015212000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-04016-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4016"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04016-5","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"The study protocol was approved by the Institutional Review Board of the Affiliated 3201 Hospital of Xi`an Jiaotong University Health Science Center (No. LLSC-KYLW-2025-032) and conducted in accordance with the ethical standards of Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication ofthis case report and the accompanying images. All the authors approved the manuscript for publication. All participants duly signed informed consent forms for the publication of case reports.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"362"}}